| Dr Robert Hepler, DDS | |
|
721 S Union Ave, Alliance, OH 44601-2932 | |
| (330) 821-0441 | |
| (330) 821-2549 |
| Full Name | Dr Robert Hepler |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 721 S Union Ave, Alliance, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053406082 | NPI | - | NPPES |
| 0286319 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 14487 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Hepler, DDS 721 S Union Ave, Alliance, OH 44601-2932 Ph: (330) 821-0441 | Dr Robert Hepler, DDS 721 S Union Ave, Alliance, OH 44601-2932 Ph: (330) 821-0441 |
News Archive
StemCells, Inc. announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of the Company's proprietary HuCNS-SC® product candidate (purified human neural stem cells) in chronic spinal cord injury. The trial is designed to assess both safety and preliminary efficacy in patients with varying degrees of paralysis who are three to 12 months post-injury, and will progressively enroll patients based upon the severity of injury.
CBS News reports that for many seniors and their families, home care needs create a serious financial bind.
Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
The incidence of tickborne infections in the United States has risen significantly within the past decade. It is imperative, therefore, that public health officials and scientists build a robust understanding of pathogenesis, design improved diagnostics, and develop preventive vaccines, according to a new commentary in the New England Journal of Medicine from leading scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health
The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.
› Verified 3 days ago
Dr. Thomas S Dietrich, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1455 S Sawburg Rd, Alliance, OH 44601 Phone: 330-821-4187 | |
Dr. Timothy John Yannone, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2720 S Union Ave, Alliance, OH 44601 Phone: 330-823-5294 Fax: 330-823-3570 | |
Dr. Kristine L Sigworth, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2825 S Union Ave, Alliance, OH 44601 Phone: 330-823-6189 Fax: 330-823-7710 | |
Dr. Benjamin M Utterback, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1360 S Sawburg Rd, Alliance, OH 44601 Phone: 330-821-6603 Fax: 330-821-2186 | |
Dr. Yong Soo Ahn, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1390 S Arch Ave, Alliance, OH 44601 Phone: 330-821-3961 Fax: 330-821-0232 | |
Dr. Edward Alan Lohnes, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2155 Parkway Blvd, Alliance, OH 44601 Phone: 330-823-5830 Fax: 330-823-8550 |